Skip to content

VAMEDIX

Active
Private limited companyfounded 2025active for 1 yearScheldekaai 1/A000, 9820 Merelbeke-Melle, BelgiumKBO/BCE: BE 1028.303.730
Summary

VAMEDIX has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9,838 and a net result of €9,338. Its solvency ranks better than 56% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 29-09-2025 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.380.030.404 2050 Antwerpen, since 29-09-2025
Financial year end
31 December
Peppol
Reachable

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€11,864
Turnover
≈ €75,000
estimated
Profit
€9,338
Equity
€9,838
Total assets
€14,276
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 3.22, cash €13,686Figures for financial year 2025 (filed on 29-06-2026)Equity €9,838 (68.9% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 69% of micro companies in human health (NACE 86)
Financial strength
Strong
Solvency 94
equity 68.9% of total assets
Liquidity 87
short-term debt 31.1% · cash 95.9%
Profitability 100
return on assets 65.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Credit of up to €500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.22, above the usual 1.5. Short-term debt is 31.1% and cash 95.9% of total assets. 31.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 57% of them on solvency, 70% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 3.22, cash €13,686
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 29-06-2026)
NBB · annual accounts
lowers risk · Equity €9,838 (68.9% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
32 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Key points

  • Caution: Less equity than 88% of companies in human healthsector median €124,659 · 20,702 companies €9,838 View

Recent changes

  1. · Gazette deed IncorporationStarting capital €500 · Appointment: Helena Van Haecke (director) · Permanent representative: Helena Van Haecke
All 2 events

Comparable companies

These companies have the same main activity as VAMEDIX: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €11,700 and €17,900, founded in 2025.

CompanyTotal assetsGross margin
VAMEDIX Merelbeke-Melle€14,276€11,864
AVS Lungcare Aalst€12,517€11,397
Dr. Andreas De Paepe Kapellen€15,096€10,422
Del'Onco Gent€11,740€10,790
THGI Onco Wetteren€13,421€8,977
MARIE PONCELET Braine-le-Château€15,358€13,763
Dr. Désirée Coppens Holsbeek€17,870€11,665
Full comparison

Key facts about VAMEDIX

What is the company number of VAMEDIX?
The company number of VAMEDIX is 1028.303.730. The VAT number is the same number with BE in front: BE 1028.303.730.
Where is VAMEDIX based?
The registered office is at Scheldekaai 1/A000, 9820 Merelbeke-Melle.Company details
What does VAMEDIX do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of VAMEDIX?
The legal form of VAMEDIX is Private limited company (BV).
When was VAMEDIX founded?
VAMEDIX was founded on 29-09-2025.
Is VAMEDIX still active?
Yes, VAMEDIX is an active enterprise in the KBO register.
What is the turnover of VAMEDIX?
The turnover in financial year 2025 is ≈ €75,000. This figure is estimated from the gross margin of €11,864 and 48 comparable companies (NACE 86). It probably lies between €51,000 and €120,000. It is a rough estimate.Financials
Is VAMEDIX profitable?
In financial year 2025, VAMEDIX made a profit of €9,338.
Where can I find the annual accounts of VAMEDIX?
VAMEDIX filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.